Anti-fungal Drugs Market: By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Anti-fungal Drugs Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Azoles, Polyenes, Echinocandins, Allylamines, Others), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications (Aspergillosis, Candidiasis, Dermatophytosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drug stores, Online pharmacies) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Antifungal drugs market size was valued at US$ 15,812.5 million in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030. The global market provides a detailed overview that can be segmented by drug type, route of administration, Therapeutic indication, and distribution channel. By drug type, the market growth has been segmented into Azoles, Polyenes, Echinocandins, Allylamines, and Others.

The Azoles segment is likely to be the largest and fastest-growing segment in terms of drug type. Azoles are used to treat candidemia, blastomycosis, ocular fungal infections, and systemic candidiasis. It helps in fungistatic activities by hindering fungal enzymes. Azoles are also utilized in the treatment of systemic fungal infections, divided into imidazoles and triazoles. They provide an extensive spectrum of activity along with improved safety levels. Triazoles have less severe effects, fewer serious drug interactions, and enhanced distribution and absorption properties.

The above-mentioned advantages of the use of azoles are attributed to the market share. Based on the Route of administration, the market is segmented into Oral, Parenteral, and Topical. Among these, the Topical route of administration segment is expected to have a significantly growing market during the forecast period. Based on the Therapeutic indication, the market is segmented into Aspergillosis, Candidiasis, Dermatophytosis, and Others.

The Candidiasis segment is expected to have a significant share in 2021. Candidiasis is the most frequently happening systemic fungal infection. It is a yeast infection by the genus Candida. Its process to cure has changed over time. Some of the variations comprise suitable usage of broad-spectrum azoles and echinocandins for the treatment of candidemia, invasive candidiasis, and mucosal candidiasis. Based on the distribution channel, the market is segmented into Retail pharmacies, Hospital pharmacies, Drug stores, and Online pharmacies.

Anti-fungal Drugs Market Key Development:

  • In June 2021, Mankind Pharma launched Posaconazole Gastro which was a tablet for drug resistance.
  • In June 2021, Cadila Pharmaceuticals launched Posaconazole which can be used against an extensive range of fungal disorders.

summary download arrow Download Free Sample

Global Anti Fungal Drugs Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.3%

Largest Market

North America

Fastest Growing Market

Asia pacific

Anti-fungal Drugs Market Dynamics

The growing incidences of nosocomial and fungal infections are anticipated to propel the market growth over the forecast years. Moreover, the growing healthcare expenditure, which helps in refining its infrastructure, is burgeoning the market growth over the forecast years.

Global Anti Fungal Drugs Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 15,812.5 million

Market CAGR

4.3%

By Drug Class

  • Azoles
  • Polyenes
  • Echinocandins
  • Allylamines
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Topical

By Therapeutic Indication

  • Aspergillosis
  • Candidiasis
  • Dermatophytosis
  • Others

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Drug stores
  • Online pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The anti-fungal drugs market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global antifungal drugs market size was valued at US$ 15,812.5 million in 2023 and is projected to grow at a CAGR of 4.3% from 2024 to 2030.

The market key players are: Pfizer, Inc. (U.S.) Novartis AG (Switzerland) Sanofi (France) Merck & Co., Inc. (U.S.) Enzon Pharmaceuticals, Inc. (U.S.) Bayer AG (Germany) Astellas Pharma, Inc. (Japan) GlaxoSmithKline plc. (U.K.) Mylan N.V. (U.S.) Tecan Group (Switzerland) AureoGen Biosciences Inc. (U.S.)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Anti-fungal Drugs Market Introduction
2.1. Global Anti-fungal Drugs Market – Taxonomy
2.2. Global Anti-fungal Drugs Market – Definitions
2.2.1. Drug Class
2.2.2. Route of Administration
2.2.3. Therapeutic Indications
2.2.4. Distribution Channel
3. Global Anti-fungal Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anti-fungal Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Anti-fungal Drugs Market – Competition Landscape
3.7. Epidemiology
4. Global Anti-fungal Drugs Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Anti-fungal Drugs Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Azoles
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Polyenes
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Echinocandins
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Allylamines
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Anti-fungal Drugs Market Forecast, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Oral
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Parenteral
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Topical
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Anti-fungal Drugs Market Forecast, By Therapeutic Indications, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Aspergillosis
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Candidiasis
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Dermatophytosis
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Anti-fungal Drugs Market Forecast (2019 - 2023 and 2024 - 2030)
8.1. Retail Pharmacies
8.1.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospital Pharmacies
8.2.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Drug Stores
8.3.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Online Pharmacies
8.4.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Anti-fungal Drugs Market Forecast by Region (2019 - 2023 and 2024 - 2030)
9.1. North America
9.1.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis (2019 - 2023 and 2024 - 2030) (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
10. Global Anti-fungal Drugs Market - Opportunity Analysis Index
10.1. By Drug Class, Route of Administration, Therapeutic Indications, Distribution Channel, and Region (2024 - 2030)
11. North America Anti-fungal Drugs Market Analysis (2019 - 2023 and 2024 - 2030)
11.1. Drug Class Analysis
11.1.1. Azoles
11.1.2. Polyenes
11.1.3. Echinocandins
11.1.4. Allylamines
11.1.5. Others
11.2. Route of Administration Analysis
11.2.1. Oral
11.2.2. Parenteral
11.2.3. Topical
11.3. Therapeutic Indications Analysis
11.3.1. Aspergillosis
11.3.2. Candidiasis
11.3.3. Dermatophytosis
11.3.4. Others
11.4. Distribution Channel Analysis
11.4.1. Retail Pharmacies
11.4.2. Hospital Pharmacies
11.4.3. Drug Stores
11.4.4. Online Pharmacies
11.5. Country Analysis
11.5.1. U.S.
11.5.2. Canada
11.6. North America Anti-fungal Drugs Market - Opportunity Analysis Index
Continue this format for sections 12, 13, and 14 for Europe, Asia-Pacific, and Latin America, respectively.
12. Europe Anti-fungal Drugs Market Analysis (2019 - 2023 and 2024 - 2030)
12.1. Drug Class Analysis
12.1.1. Azoles
12.1.2. Polyenes
12.1.3. Echinocandins
12.1.4. Allylamines
12.1.5. Others
12.2. Route of Administration Analysis
12.2.1. Oral
12.2.2. Parenteral
12.2.3. Topical
12.3. Therapeutic Indications Analysis
12.3.1. Aspergillosis
12.3.2. Candidiasis
12.3.3. Dermatophytosis
12.3.4. Others
12.4. Distribution Channel Analysis
12.4.1. Retail Pharmacies
12.4.2. Hospital Pharmacies
12.4.3. Drug Stores
12.4.4. Online Pharmacies
12.5. Country Analysis
12.5.1. Germany
12.5.2. UK
12.5.3. France
12.5.4. Spain
12.5.5. Italy
12.5.6. Russia
12.5.7. Poland
12.5.8. Rest of Europe
12.6. Europe Anti-fungal Drugs Market - Opportunity Analysis Index
13. Asia-Pacific Anti-fungal Drugs Market Analysis (2019 - 2023 and 2024 - 2030)
13.1. Drug Class Analysis
13.1.1. Azoles
13.1.2. Polyenes
13.1.3. Echinocandins
13.1.4. Allylamines
13.1.5. Others
13.2. Route of Administration Analysis
13.2.1. Oral
13.2.2. Parenteral
13.2.3. Topical
13.3. Therapeutic Indications Analysis
13.3.1. Aspergillosis
13.3.2. Candidiasis
13.3.3. Dermatophytosis
13.3.4. Others
13.4. Distribution Channel Analysis
13.4.1. Retail Pharmacies
13.4.2. Hospital Pharmacies
13.4.3. Drug Stores
13.4.4. Online Pharmacies
13.5. Country Analysis
13.5.1. Japan
13.5.2. China
13.5.3. India
13.5.4. ASEAN
13.5.5. Australia & New Zealand
13.5.6. Rest of Asia-Pacific
13.6. Asia-Pacific Anti-fungal Drugs Market - Opportunity Analysis Index
14. Latin America Anti-fungal Drugs Market Analysis (2012 - 2019 - 2023 and 2024 - 2030)
14.1. Drug Class Analysis
14.1.1. Azoles
14.1.2. Polyenes
14.1.3. Echinocandins
14.1.4. Allylamines
14.1.5. Others
14.2. Route of Administration Analysis
14.2.1. Oral
14.2.2. Parenteral
14.2.3. Topical
14.3. Therapeutic Indications Analysis
14.3.1. Aspergillosis
14.3.2. Candidiasis
14.3.3. Dermatophytosis
14.3.4. Others
14.4. Distribution Channel Analysis
14.4.1. Retail Pharmacies
14.4.2. Hospital Pharmacies
14.4.3. Drug Stores
14.4.4. Online Pharmacies
14.5. Country Analysis
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Argentina
14.5.4. Venezuela
14.5.5. Rest of Latin America
14.6. Latin America Anti-Fungal Drugs Market - Opportunity Analysis Index
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Pfizer, Inc. (U.S.)
 15.2.2. Novartis AG (Switzerland)
 15.2.3. Sanofi (France)
15.2.4. Merck & Co., Inc. (U.S.)
 15.2.5. Enzon Pharmaceuticals, Inc. (U.S.)
15.2.6. Bayer AG (Germany)
 15.2.7. Astellas Pharma, Inc. (Japan)
15.2.8. GlaxoSmithKline plc. (U.K.)
 15.2.9. Mylan N.V. (U.S.), Tecan Group (Switzerland)
 15.2.10. AureoGen Biosciences Inc. (U.S.)
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Pfizer, Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Sanofi (France)
  • Merck & Co., Inc. (U.S.)
  • Enzon Pharmaceuticals, Inc. (U.S.)
  • Bayer AG (Germany)
  • Astellas Pharma, Inc. (Japan)
  • GlaxoSmithKline plc. (U.K.)
  • Mylan N.V. (U.S.)
  • Tecan Group (Switzerland)
  • AureoGen Biosciences Inc. (U.S.)

Related Industry Reports

Cytotoxic Drugs Market

Female Fertility Drugs Market

Asia Pacific Antifungal Drugs Market

Global Antiretroviral Drugs Market